EGFR and colorectal cancer: A short hairpin RNA (shRNA) screen of human kinases and several kinase-related genes revealed that knockdown of epidermal growth factor receptor (EGFR) synergized with PLX4032, a BRAF inhibitor, in the suppression of BRAFV600E mutant colorectal cancers [23].